Text Size
2703 studies found for:    "Endocrine Gland Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Conditions: Sarcoma;   Endocrine Tumors;   Neuroblastoma;   Retinoblastoma;   Renal Cancer
Intervention:
22 Recruiting Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Hepatic Metastases;   Metastases
Interventions: Drug: Everolimus;   Device: embolization;   Drug: Doxorubicin
23 Terminated
Has Results 		Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
Condition: Pancreatic Cancer
Interventions: Drug: Avastin;   Drug: Fluorouracil;   Drug: Doxorubicin;   Drug: Streptozocin;   Drug: Dexamethasone;   Drug: Ondansetron
24 Recruiting Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Conditions: Acromegaly;   Gigantism;   Familial Isolated Pituitary Adenoma;   FIPA;   Pituitary Adenoma Predisposition;   PAP
Intervention:
25 Recruiting RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Conditions: Carcinoma;   Neuroendocrine;   Non Functioning Neuroendocrine Tumors/NET;   Non Syndromic Neuroendocrine Tumors/NET;   Carcinoids;   Non Functioning
Intervention: Drug: Everolimus
26 Completed Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
Conditions: Carcinoma;   Carcinoma, Renal Cell;   Neuroendocrine Tumors;   Carcinoid Tumor;   Pancreatic Islet Cell Tumors
Intervention: Other: Blood sampling by vena punction.
27 Active, not recruiting A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
Condition: Neoplasms
Interventions: Drug: bevacizumab [Avastin];   Drug: 5 FU;   Drug: Streptozotocin;   Drug: Xeloda
28 Enrolling by invitation Genetic Evaluation of Families With Endocrine Cancers
Conditions: Pancreatic Cancer;   Thymic Cancer;   Parathyroid Disease;   MEN1 Syndrome
Intervention: Genetic: Blood draw
29 Unknown † Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
Conditions: Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Neoplastic Syndrome
Interventions: Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium
30 Completed Vancomycin Associated Red Man Syndrome (RMS)
Condition: Red Man Syndrome
Intervention:
31 Completed Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
Conditions: Muscle Rigidity;   Spasm;   Stiff Man Syndrome
Intervention: Drug: IVIg
32 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
33 Recruiting ImmunoTEP for Patients With Medullary Thyroid Carcinoma.
Condition: Medullary Thyroid Carcinoma
Intervention: Drug: • TF2 and 68 Ga-IMP-288
34 Terminated GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas;   Advanced Solid Tumors;   Cancer;   Cancer of Pancreas;   Cancer of the Pancreas;   Metastases;   Metastatic Cancer;   Metastatic Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Cancer;   Bone Metastases;   Endocrine Cancer;   Oncology;   Oncology Patients;   Solid Tumors;   Advanced Malignancy
Interventions: Drug: AMG 479;   Drug: Placebo;   Drug: gemcitabine
35 Completed B-Receptor Signaling in Cardiomyopathy
Conditions: Carcinomas;   Amyloidosis;   Anal Cancer;   Anemia;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Transitional Cell Carcinoma of Bladder;   Bone Marrow Transplant Failure;   Bone Cancer;   Cancer of Brain and Nervous System;   Breast Cancer;   Carcinoma of the Large Intestine;   Endocrine Cancer;   Esophageal Cancer;   Eye Cancer;   Gall Bladder Cancer;   Gastric (Stomach) Cancer;   Gastrooesophageal Cancer;   Gastrointestinal Stromal Tumor (GIST);   Gynecologic Cancers;   Head and Neck Cancers;   Hepatobiliary Neoplasm;   Kidney (Renal Cell) Cancer;   Leukemia;   Lung Cancer;   Hodgkin Disease;   Lymphoma, Non-Hodgkin;   Mesothelioma;   Multiple Myeloma;   Myelodysplastic Syndromes (MDS);   Neuroendocrine Tumors;   Myeloproliferative Disorders;   Pancreatic Cancer;   Prostate Cancer;   Skin Cancer;   Soft Tissue Sarcoma;   Testicular Cancer;   Thymus Cancer;   Thyroid Cancer
Intervention:
36 Active, not recruiting Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Conditions: Breast Cancer;   Hypercalcemia of Malignancy;   Colon Cancer;   Endocrine Cancer;   Head and Neck Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Metastatic Cancer;   Multiple Myeloma;   Parathyroid Neoplasms;   Renal Cancer;   Thyroid Cancer;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Non-Small Cell Lung Cancer
Intervention: Drug: denosumab
37 Active, not recruiting Phase I Study of Cixutumumab and mTOR Inhibitor, Everolimus, in Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Conditions: Endocrine Cancer;   Metastatic Gastrointestinal Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Neuroendocrine Carcinoma of the Skin;   Stage IV Neuroendocrine Carcinoma of the Skin;   Thyroid Gland Medullary Carcinoma
Interventions: Biological: cixutumumab;   Drug: octreotide acetate;   Drug: everolimus;   Other: pharmacological study;   Other: laboratory biomarker analysis
38 Completed Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
39 Active, not recruiting Diagnostic Study of Patients With Stage I Testicular Cancer
Condition: Testicular Germ Cell Tumor
Interventions: Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: radionuclide imaging
40 Completed EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Intervention: Drug: epothilone b
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years